
Larimar Therapeutics, Inc.: shareholders and insiders
Price
$3.14
November 20, 2026Market cap $326M
What Ploutos Investor adds for Larimar Therapeutics
Part of Ploutos Investor, €9.99 a month
- The full history: 14 fiscal years, from 2012
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Nov 18, 2026, from their own Form 4 filings.
Bought on the market
$26M
10 people
Sold on the market
–
nobody
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $26M by 10 people·no sales
- 2025: no buys, no sales
- 2026: bought $26M by 10 people, no sales
- Nov 16, 2026Russell ClaytonChief Medical OfficerKind
- Nov 16, 2026Jeffrey W ShermanDirectorKind
- Nov 12, 2026Thomas Edward HamiltonDirectorKind
- Nov 11, 2026Carole Ben-maimonPresident and CEOKind
- Nov 11, 2026Frank E ThomasDirectorKind
- Nov 11, 2026Joseph TruittDirectorKind
- Nov 11, 2026John B. Harlow Jr.President and COOKind
- Nov 11, 2026Michael CelanoChief Financial OfficerKind
- Nov 11, 2026Gopi ShankarChief Development OfficerKind
- Sep 29, 2026John B. Harlow Jr.President and COOKind
- Jul 6, 2026Thomas Edward HamiltonDirectorKind
- Feb 27, 2026Jeffrey W ShermanKind
- Feb 27, 2026Frank E ThomasKind
- Feb 27, 2026Thomas Edward HamiltonKind
- Feb 27, 2026Deerfield Mgmt HIF, L.P.Kind
- Feb 27, 2026Deerfield Mgmt HIF, L.P.Kind
- Feb 27, 2026Deerfield Mgmt HIF, L.P.Kind
- Feb 27, 2026Deerfield Mgmt HIF, L.P.Kind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Russell ClaytonChief Medical Officer | 3,322 | $3.01 | $10.0K | Form 4 | |
| Nov 16, 2026 | Jeffrey W ShermanDirector | 3,289 | $3.06 | $10.1K | Form 4 | |
| Nov 12, 2026 | Thomas Edward HamiltonDirector | 70.0K | $2.67 | $187.1K | Form 4 | |
| Nov 11, 2026 | Carole Ben-maimonPresident and CEO | 18.1K | $2.77 | $50.0K | Form 4 | |
| Nov 11, 2026 | Frank E ThomasDirector | 8,000 | $2.73 | $21.8K | Form 4 | |
| Nov 11, 2026 | Joseph TruittDirector | 3,500 | $2.80 | $9.8K | Form 4 | |
| Nov 11, 2026 | John B. Harlow Jr.President and COO | 17.8K | $2.80 | $49.9K | Form 4 | |
| Nov 11, 2026 | Michael CelanoChief Financial Officer | 18.5K | $2.71 | $50.0K | Form 4 | |
| Nov 11, 2026 | Gopi ShankarChief Development Officer | 5,000 | $2.71 | $13.5K | Form 4 | |
| Sep 29, 2026 | John B. Harlow Jr.President and COO | 50.0K | – | – | Form 4 | |
| Jul 6, 2026 | Thomas Edward HamiltonDirector | 50.0K | $3.34 | $166.9K | Form 4 | |
| Feb 27, 2026 | Jeffrey W Sherman | 5,000 | $5.00 | $25.0K | Form 4 | |
| Feb 27, 2026 | Frank E Thomas | 5,000 | $5.00 | $25.0K | Form 4 | |
| Feb 27, 2026 | Thomas Edward Hamilton | 100.0K | $5.00 | $500.0K | Form 4 | |
| Feb 27, 2026 | Deerfield Mgmt HIF, L.P. | 1.08M | $5.00 | $5.4M | Form 4 | |
| Feb 27, 2026 | Deerfield Mgmt HIF, L.P. | 832.0K | $5.00 | $4.2M | Form 4 | |
| Feb 27, 2026 | Deerfield Mgmt HIF, L.P. | 2.00M | $5.00 | $10M | Form 4 | |
| Feb 27, 2026 | Deerfield Mgmt HIF, L.P. | 1.08M | $5.00 | $5.4M | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 8, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by LRMR's officers and directors from 2014 up to November 21, 2025, 12 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 7 more, back to 2014
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Deerfield Private Design Fund III, L.P.with 9 more personsShare of class34.4%
- Blue Owl Capital Holdings LPShare of class9.99%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P.with 9 more persons | 34.4% | 35.67M | Mar 2, 20262 filings since Jul 31, 2025 | 13D/A | |
| Blue Owl Capital Holdings LP | 9.99% | 10.74M | May 14, 20262 filings since Feb 12, 2026 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Deerfield Private Design Fund III, L.P.34.4%From the filing of Mar 2, 2026
Item 4 of the Schedule 13D is hereby amended by adding the following: Each Fund acquired its February 2026 Shares for investment purposes in an underwritten offering conducted by the Company (the "February 2026 Offering") pursuant to the Prospectus Supplement, dated as of February 25, 2026, to the Issuer's Prospectus, dated as of May 24, 2024 (the "February 2026 Offering").
From the filing of Mar 2, 2026
Fell to 5% or less (6)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter-95%
- Millennium Mgmt (Englander)In the quarter+25%
- D.E. ShawIn the quarter
- Renaissance TechnologiesIn the quarter-38%
- AQR CapitalIn the quarter-5.5%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | – | – | 0.00% | |
| Citadel Advisors (Griffin) | 66.4K | -95% | $200.0K | 0.00% |
| Millennium Mgmt (Englander) | 1.67M | +25% | $5.3M | 0.00% |
| D.E. Shaw | 568.6K | $1.8M | 0.00% | |
| Renaissance Technologies | 184.0K | -38% | $600.0K | 0.00% |
| AQR Capital | 2.24M | -5.5% | $7.2M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 14.1% of its shares outstanding were held short, -4.6% since the report before.
- Shares held short
- 14.66M
- 14.1%
- Since the report before15.37M on Sep 30, 2026
- -4.6%
- 9.0
- 1.64M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 88%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 576.9K
- Nov 15, 2023: Shares held short 527.4K
- Nov 30, 2023: Shares held short 486.4K
- Dec 15, 2023: Shares held short 406.1K
- Dec 29, 2023: Shares held short 390.0K
- Jan 12, 2024: Shares held short 357.1K
- Jan 31, 2024: Shares held short 339.7K
- Feb 15, 2024: Shares held short 618.2K
- Feb 29, 2024: Shares held short 506.8K
- Mar 15, 2024: Shares held short 1.63M
- Mar 28, 2024: Shares held short 3.19M
- Apr 15, 2024: Shares held short 3.63M
- Apr 30, 2024: Shares held short 3.90M
- May 15, 2024: Shares held short 3.91M
- May 31, 2024: Shares held short 3.22M
- Jun 14, 2024: Shares held short 3.27M
- Jun 28, 2024: Shares held short 2.88M
- Jul 15, 2024: Shares held short 3.63M
- Jul 31, 2024: Shares held short 3.48M
- Aug 15, 2024: Shares held short 3.63M
- Aug 30, 2024: Shares held short 3.47M
- Sep 13, 2024: Shares held short 3.33M
- Sep 30, 2024: Shares held short 3.57M
- Oct 15, 2024: Shares held short 3.71M
- Oct 31, 2024: Shares held short 2.72M
- Nov 15, 2024: Shares held short 3.31M
- Nov 29, 2024: Shares held short 3.88M
- Dec 13, 2024: Shares held short 4.47M
- Dec 31, 2024: Shares held short 5.07M
- Jan 15, 2025: Shares held short 5.24M
- Jan 31, 2025: Shares held short 5.07M
- Feb 14, 2025: Shares held short 5.38M
- Feb 28, 2025: Shares held short 5.09M
- Mar 14, 2025: Shares held short 5.08M
- Mar 31, 2025: Shares held short 4.82M
- Apr 15, 2025: Shares held short 5.63M
- Apr 30, 2025: Shares held short 5.97M
- May 15, 2025: Shares held short 9.83M
- May 30, 2025: Shares held short 6.37M
- Jun 13, 2025: Shares held short 6.49M
- Jun 30, 2025: Shares held short 6.26M
- Jul 15, 2025: Shares held short 6.15M
- Jul 31, 2025: Shares held short 6.37M
- Aug 15, 2025: Shares held short 5.89M
- Aug 29, 2025: Shares held short 6.40M
- Sep 15, 2025: Shares held short 7.65M
- Sep 30, 2025: Shares held short 8.94M
- Oct 15, 2025: Shares held short 8.82M
- Oct 31, 2025: Shares held short 9.10M
- Nov 14, 2025: Shares held short 10.08M
- Nov 28, 2025: Shares held short 9.80M
- Dec 15, 2025: Shares held short 7.92M
- Dec 31, 2025: Shares held short 8.24M
- Jan 15, 2026: Shares held short 8.59M
- Jan 30, 2026: Shares held short 8.77M
- Feb 13, 2026: Shares held short 8.98M
- Feb 27, 2026: Shares held short 7.69M
- Mar 13, 2026: Shares held short 7.26M
- Mar 31, 2026: Shares held short 7.64M
- Apr 15, 2026: Shares held short 7.33M
- Apr 30, 2026: Shares held short 8.31M
- May 15, 2026: Shares held short 8.74M
- May 29, 2026: Shares held short 8.05M
- Jun 15, 2026: Shares held short 10.54M
- Jun 30, 2026: Shares held short 12.19M
- Jul 15, 2026: Shares held short 11.30M
- Jul 31, 2026: Shares held short 12.19M
- Aug 14, 2026: Shares held short 13.44M
- Aug 31, 2026: Shares held short 13.72M
- Sep 15, 2026: Shares held short 13.89M
- Sep 30, 2026: Shares held short 15.37M
- Oct 15, 2026: Shares held short 14.66M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading54.6% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 54.6% of the shares in the reported trades were short sales, against 49.4% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 54.6%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 49.4%
- Change
- +5.2 pts
- Short sales a dayon average, of 480.3K shares
- 262.3K
- More than atof 3,666 US-listed companies, same days
- 65%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 45.4%
- Oct 15, 2026: Short sales 45.1%
- Oct 16, 2026: Short sales 51.8%
- Oct 19, 2026: Short sales 57.4%
- Oct 20, 2026: Short sales 64.9%
- Oct 21, 2026: Short sales 63.7%
- Oct 22, 2026: Short sales 43.1%
- Oct 23, 2026: Short sales 60.1%
- Oct 26, 2026: Short sales 29.7%
- Oct 27, 2026: Short sales 36.5%
- Oct 28, 2026: Short sales 50.5%
- Oct 29, 2026: Short sales 69%
- Oct 30, 2026: Short sales 49.2%
- Nov 2, 2026: Short sales 42.7%
- Nov 3, 2026: Short sales 65.3%
- Nov 4, 2026: Short sales 60.1%
- Nov 5, 2026: Short sales 49.3%
- Nov 6, 2026: Short sales 71.9%
- Nov 9, 2026: Short sales 44.8%
- Nov 10, 2026: Short sales 67.2%
- Nov 11, 2026: Short sales 43.8%
- Nov 12, 2026: Short sales 49.1%
- Nov 13, 2026: Short sales 52.4%
- Nov 16, 2026: Short sales 59.7%
- Nov 17, 2026: Short sales 52.1%
- Nov 18, 2026: Short sales 41.9%
- Nov 19, 2026: Short sales 56.8%
- Nov 20, 2026: Short sales 54.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Deerfield Mgmt HIF, L.P.Director,TenPercentOwner,OtherDirectly–
- Deerfield Mgmt L.P.Director,TenPercentOwner,OtherDirectly–
- Thomas Edward HamiltonDirectorDirectly944.2K
- Carole Ben-maimonPresident and CEODirectly542.1K
- Michael CelanoChief Financial OfficerDirectly234.2K
- Gopi ShankarChief Development OfficerDirectly81.4K
- Russell ClaytonChief Medical OfficerDirectly74.8K
- John B. Harlow Jr.President and COODirectly67.8K
- Frank E ThomasDirectorDirectly15.0K
- Jeffrey W ShermanDirectorDirectly8,289
- Joseph TruittDirectorDirectly6,250
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Deerfield Mgmt HIF, L.P.Director,TenPercentOwner,Other | – | 10.62M | Feb 27, 2026 | Form 4 |
| Deerfield Mgmt L.P.Director,TenPercentOwner,Other | – | 4.21M | Feb 16, 2024 | Form 4 |
| Thomas Edward HamiltonDirector | 944.2K | – | Nov 12, 2026 | Form 4 |
| Carole Ben-maimonPresident and CEO | 542.1K | – | Nov 11, 2026 | Form 4 |
| Michael CelanoChief Financial Officer | 234.2K | – | Nov 11, 2026 | Form 4 |
| Gopi ShankarChief Development Officer | 81.4K | – | Nov 11, 2026 | Form 4 |
| Russell ClaytonChief Medical Officer | 74.8K | – | Nov 16, 2026 | Form 4 |
| John B. Harlow Jr.President and COO | 67.8K | – | Nov 11, 2026 | Form 4 |
| Frank E ThomasDirector | 15.0K | – | Nov 11, 2026 | Form 4 |
| Jeffrey W ShermanDirector | 8,289 | – | Nov 16, 2026 | Form 4 |
| Joseph TruittDirector | 6,250 | – | Nov 11, 2026 | Form 4 |
A lower bound: it counts only the 11 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.04%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.04%
- IBBiShares Biotechnology ETFWeight in the fund0.01%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.01%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- VHTVanguard Health Care Index FundWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- DFACDimensional U.S. Core Equity 2 ETFWeight in the fund0.00%
13 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 136
- Q4 2025: Managers 136
- Q1 2026: Managers 163
- Q2 2026: Managers 163
Institutional investors by quarter
The fund managers holding LRMR, quarter by quarter, from Q2 2020 to Q2 2025, 21 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 163 managers held 95.45M shares, worth $293M. During the quarter 33 opened a position, 33 closed one, 66 added and 40 trimmed.
The largest holders, Q2 2026
- Deerfield ManagementIn the quarter
- Blue Owl Capital HoldingsIn the quarter+29%
- BlackRockIn the quarter+51%
- Defilade Capital ManagementIn the quarter
- Driehaus Capital ManagementIn the quarter+7.8%
- Vanguard Capital ManagementIn the quarter+3.8%
- Rtw InvestmentsIn the quarter+71%
- AQR CapitalIn the quarter+190%
- Marshall WaceIn the quarter+116%
- DAFNA Capital ManagementIn the quarter-1.0%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Deerfield Management | 35.61M | $109M | |
| Blue Owl Capital Holdings | 9.16M | +29% | $28M |
| BlackRock | 5.68M | +51% | $17M |
| Defilade Capital Management | 3.67M | $11M | |
| Driehaus Capital Management | 3.16M | +7.8% | $9.6M |
| Vanguard Capital Management | 2.97M | +3.8% | $9.1M |
| Rtw Investments | 2.57M | +71% | $7.8M |
| AQR Capital | 2.37M | +190% | $7.2M |
| Marshall Wace | 2.01M | +116% | $6.1M |
| DAFNA Capital Management | 2.01M | -1.0% | $6.1M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Larimar Therapeutics's filings show?
Who buys and sells is one part of Larimar Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have LRMR's insiders bought or sold?
From Jul 8, 2026 to Nov 18, 2026 Larimar Therapeutics's insiders bought $569.0K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.
Which well-known managers hold LRMR?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $7.2M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.